US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 32.190
  • +0.350+1.10%
Close Jan 3 16:00 ET
  • 32.190
  • 0.0000.00%
Post 16:20 ET
1.84BMarket Cap2.76P/E (TTM)

Agios Pharmaceuticals Key Stats

Agios Pharmaceuticals Q3 2024 Earnings Date

Currency:USDOct 31, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
9.50M
8.96M
-538.09K
Miss Est.
+28.42%
+21.15%
-5.66%
EPS
8.69
16.22
+7.53
Beat Est.
+629.66%
+1089.02%
+86.74%
Strong Buy

Jan 5, 2025

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.768M--
--2024/Q4-- / 9.298M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.768M--
--2024/Q4-- / 9.298M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Jan 5, 2025

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data